Providence Medical Institute

2121 Santa Monica Boulevard
Santa Monica, California 90404

We've found

1 trials

at this facility

The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Santa Monica, CA

Use our guide to learn which trials are right for you!